Stock Price Quote

NOVARTIS INDIA LTD.

NSE : NOVARTINDBSE : 500672ISIN CODE : INE234A01025Industry : TradingHouse : Novartis India - MNC
BSE803.004.1 (+0.51 %)
PREV CLOSE ( ) 798.90
OPEN PRICE ( ) 794.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8496
TODAY'S LOW / HIGH ( )791.10 824.85
52 WK LOW / HIGH ( )744.95 1248
NSE672.250 (0 %)
PREV CLOSE( ) 672.25
OPEN PRICE ( ) 691.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 672.25 (249)
VOLUME 11837
TODAY'S LOW / HIGH( ) 668.35 698.20
52 WK LOW / HIGH ( )668.35 698.2
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-12 1947
Management Info
Christopher Snook - Chairman - Managing Director
Registered Office

Address The Inspire B K C, 7th Floor,Bandra Kurla Complex,Bandra (East),
Mumbai,
Maharashtra-400051

Phone 022-50243000

Email india.investors@novartis.com

Website www.novartis.in

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

04Jul Novartis India informs about loss of s
Novartis India has informed that it enclosed intimation under regulation..
15May Novartis India informs about loss of s
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..
10May Novartis India informs about board mee
In continuation to intimation dated March 27, 2024 and pursuant to Regul..
08May Novartis India informs about change in
Novartis India has informed that based on the recommendation of Nominati..
19Mar Novartis India informs about details o
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit254.5851.9
Gross Profit 352.9 1228.4
Operating Profit 361.81269.4
Net Sales 9303350.7

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

The Yamuna Syndicate (BSE)
peergroup  35377.25 (2.88%)
M.Cap ( in Cr)1087.37
India Motor Parts (BSE)
peergroup  1037.90 (4.12%)
M.Cap ( in Cr)1295.30
Sinnar Bidi Udyog (BSE)
peergroup  700.75 (4.98%)
M.Cap ( in Cr)28.03
Parshva Enterprises (BSE)
peergroup  197.50 (18.02%)
M.Cap ( in Cr)201.25
Eyantra ventures (BSE)
peergroup  1130.00 (0.91%)
M.Cap ( in Cr)226.78

Shareholding Pattern

PROMOTERS 70.68%
NON-INSTITUTION 28.61%
FI/BANKS/INSURANCE 0.52%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Novartis India Ltd.

Novartis India Ltd. was incorporated in the year 1947. Its today's share price is 803. Its current market capitalisation stands at Rs 1982.67 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3668.4 Cr and Total Income of Rs.3967.5 Cr. The company's management includes Falin Majmudar, Chandni Maru, Shilpa Joshi, Gira Sardesai, Sanker Parameswaran, Sandra Martyres, Christopher Snook, Chandni Maru.

It is listed on the BSE with a BSE Code of 500672 , NSE with an NSE Symbol of NOVARTIND and ISIN of INE234A01025. It's Registered office is at The Inspire B K C, 7th Floor,Bandra Kurla Complex,Bandra (East)Mumbai-400051, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are AF Ferguson & Co, BSR & Co LLP, Deloitte Haskins & Sells LLP, Lovelock & Lewes, Price Waterhouse

1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.
1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.
Close X
OPEN

DEMAT ACCOUNT

AND START YOUR

INVESTMENT

JOURNEY WITH US
(You will receive a Call & SMS from our end)
Popup-Character

Disclaimer: NIRMAL BANG SECURITIES PVT LTD: Investment in Securities market are subject to market risks. Read all the related documents carefully before investing. Please read the Do’s and Don’ts prescribed by the Commodity Exchange before trading. We do not offer PMS Service for the Commodity segment. Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO. The securities quoted are exemplary and are not recommendatory. BSE (Member ID- 498): INB011072759, INF011072759, Exchange Registered Member in CDS; NSE MEMEBR ID- 09391): INB230939139, INF230939139, INE230939139; MSEI Member ID-1067): INB260939138, INF260939138, INE260939139: Single Registration No. INZ000202536, PMS Registration No: INP000002981; Research Analyst Registration No: INH000001766; NSDL/ CDSL: IN-DP-CDSL 37-99; Exchange Member ID: MCX - 56460, NCDEX - 1268, ICEX – 2073. Regd. Office: B-2, 301/302, 3rd Floor, Marathon Innova, Off Ganpatrao Kadam Marg, Lower Parel (W), Mumbai - 400013. Tel: 62738000/01; Fax: 62738010 | *NIRMAL BANG NIVESHALAYA PVT LTD: ARN – 111233, Mutual Fund Distributor. Mutual Fund Investments are subject to market risks. Please read the offer documents carefully before Investing.” Regd. Office: B - 201, Khandelwal House, Poddar Road, Near Poddar Park, Malad (East). Mumbai – 400097. | **NIRMAL BANG INSURANCE BROKING PVT LTD: IRDAI Registration No: 795 and Registration Code For the Insurance Broker: IRDAI/DB889/2021. Insurance is the subject matter of the solicitation. For more details on policy terms, conditions, exclusions, limitations, please refer/read policy brochure carefully before concluding sale.